X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (496) 496
Publication (72) 72
Book Chapter (12) 12
Magazine Article (11) 11
Book Review (6) 6
Conference Proceeding (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (325) 325
melarsoprol (304) 304
animals (287) 287
trypanosomiasis, african - drug therapy (249) 249
melarsoprol - therapeutic use (158) 158
trypanocidal agents - therapeutic use (138) 138
female (135) 135
human african trypanosomiasis (131) 131
male (127) 127
index medicus (122) 122
sleeping sickness (112) 112
tropical medicine (103) 103
trypanosomiasis (99) 99
parasitology (96) 96
trypanosoma brucei gambiense (91) 91
african trypanosomiasis (89) 89
mice (86) 86
adult (85) 85
trypanocidal agents - pharmacology (85) 85
melarsoprol - pharmacology (72) 72
trypanosomiasis, african - parasitology (72) 72
drug resistance (67) 67
trypanosomiasis, african - epidemiology (64) 64
eflornithine (62) 62
middle aged (62) 62
parasitic diseases (62) 62
public, environmental & occupational health (61) 61
trypanosoma brucei brucei - drug effects (61) 61
pharmacology & pharmacy (58) 58
trypanosomiasis, african - diagnosis (58) 58
adolescent (57) 57
infectious diseases (56) 56
eflornithine - therapeutic use (53) 53
pentamidine (53) 53
chemotherapy (50) 50
melarsoprol - administration & dosage (49) 49
melarsoprol - adverse effects (48) 48
risk-factors (48) 48
brucei-gambiense (45) 45
drug therapy, combination (45) 45
microbiology (44) 44
trypanocidal agents - administration & dosage (44) 44
child (42) 42
arsenicals - therapeutic use (41) 41
pentamidine - therapeutic use (41) 41
trypanosoma brucei rhodesiense (41) 41
gambiense sleeping sickness (40) 40
suramin - therapeutic use (40) 40
trypanosoma brucei gambiense - drug effects (40) 40
recurrence (39) 39
suramin (38) 38
treatment outcome (37) 37
drug therapy (36) 36
trypanosoma brucei (36) 36
uganda (36) 36
diagnosis (34) 34
gambiense (34) 34
in-vitro (34) 34
resistance (34) 34
trypanosoma brucei rhodesiense - drug effects (34) 34
child, preschool (31) 31
drug-resistance (30) 30
efficacy (30) 30
trypanocidal agents - adverse effects (30) 30
medicine, general & internal (29) 29
nifurtimox (29) 29
aged (28) 28
arsenicals - pharmacology (28) 28
research article (27) 27
treatment failure (27) 27
trial (27) 27
trypanosoma brucei brucei - metabolism (27) 27
trypanosomiasis, african - prevention & control (27) 27
biochemistry & molecular biology (26) 26
parasites (26) 26
pentamidine - pharmacology (26) 26
analysis (25) 25
drugs (25) 25
rats (25) 25
trypanosomiasis, african (25) 25
research (24) 24
african trypanosomes (23) 23
drug administration schedule (23) 23
encephalopathy (23) 23
immunology (23) 23
nifurtimox - therapeutic use (23) 23
trypanocidal agents - pharmacokinetics (23) 23
adenosine transporter (22) 22
blood-stream forms (22) 22
brucei (22) 22
follow-up studies (22) 22
time factors (22) 22
trypanocidal agents - chemistry (22) 22
trypanosoma brucei brucei (22) 22
cerebrospinal-fluid (21) 21
congo (21) 21
cross-resistance (21) 21
failure (21) 21
trypanosomiasis, african - cerebrospinal fluid (21) 21
arsenic (20) 20
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS Neglected Tropical Diseases, ISSN 1935-2727, 09/2011, Volume 5, Issue 9, p. e1308
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 01/2002, Volume 8, Issue 4, pp. 257 - 267
Human African trypanosomiasis or sleeping sickness is resurgent. The disease is caused by subspecies of the parasitic haemoflagellate, Trypanosoma brucei.... 
melarsoprol
Journal Article
Journal Article
Journal Article
Tropical Medicine & International Health, ISSN 1360-2276, 11/2001, Volume 6, Issue 11, pp. 906 - 914
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 2/2007, Volume 195, Issue 3, pp. 322 - 329
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 2014, Volume 58, Issue 8, pp. 4452 - 4463
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 11/2013, Volume 85, Issue 3, pp. 560 - 568
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 06/2018, Volume 12, Issue 6, p. e0006504
We conducted a retrospective study on mortality trends and risk factors in 781 naive cases of advanced stage-2 sleeping sickness admitted between 1989 and 2012... 
MULTICENTER | PROTEIN | BRUCEI-GAMBIENSE | GAMBIAN TRYPANOSOMIASIS | EFLORNITHINE COMBINATION THERAPY | SCHEDULE | CEREBROSPINAL-FLUID | PARASITOLOGY | TROPICAL MEDICINE | MELARSOPROL TREATMENT | Multivariate Analysis | Recurrence | Trypanosomiasis, African - drug therapy | Nifurtimox - administration & dosage | Humans | Middle Aged | Melarsoprol - administration & dosage | Male | Melarsoprol - therapeutic use | Eflornithine - therapeutic use | Young Adult | Trypanosoma brucei gambiense - drug effects | Trypanosomiasis, African - epidemiology | Trypanosomiasis, African - mortality | Adult | Female | Trypanocidal Agents - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Eflornithine - administration & dosage | Trypanocidal Agents - administration & dosage | Risk Factors | Treatment Outcome | Hospital Records | Trypanosomiasis, African - parasitology | Democratic Republic of the Congo - epidemiology | Adolescent | Disease Management | Nifurtimox - therapeutic use | Mortality | Analysis | Africa | Congo (Kinshasa) | Epidemiology | Trypanosomiasis | Health aspects | Risk factors | Intravenous administration | Nifurtimox | Medical services | Parasites | Cerebrospinal fluid | Gender | Risks | Proteins | Regression models | Fluids | Ratios | Mathematical models | Trends | African trypanosomiasis | Vector-borne diseases | Evaluation | Computational fluid dynamics | Fluid | Duration | Regression analysis | Risk analysis | Patients | Body fluids | Neurology | Death | Eflornithine
Journal Article